EUVIMEDEUVIMED entdecken
Crossref

Breaking barriers: Nitric oxide-releasing nanocomplexes for collagen degradation and enhanced αPD-L1 immunotherapy in deep tumor

Jihye Lee, Hyoeun Cho, Jieun Kim, Junha Lim, Yeoul Kang, Won Jong Kim

Journal of Controlled Release · 2025

DOI: 10.1016/j.jconrel.2025.02.072 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2025. Verfasst von Jihye Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, POSTECH-CATHOLIC Biomedical Engineering Institute (POSTECH), Pohang 37673, South Korea. Hauptthemen laut MEDLINE: B7-H1 Antigen, Collagen, Nitric Oxide, Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Korea Ministry of Science and ICT, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Overcoming the physical barrier of the extracellular matrix (ECM) surrounding tumors is a critical challenge in achieving effective immune checkpoint blockade (ICB). The dense ECM impedes the infiltration of immune checkpoint inhibitors (ICIs) and cytotoxic T lymphocytes (CTLs) into tumor tissues. To address this, we design a nanocomplex incorporating a reactive oxygen species (ROS)-responsive nitric oxide (NO) prodrug around TANNylated αPD-L1. Within the tumor microenvironment (TME), this nanocomplex accumulates and selectively releases NO in response to ROS. The released NO activates matrix metalloproteinases (MMPs) in the ECM, leading to collagen degradation. Following this, the pH-responsive release of αPD-L1 in the deeper tumor regions ensures effective delivery, allowing CTLs to penetrate the tumor more efficiently by bypassing the ECM barrier, thereby enhancing immunotherapy. Overall, this study applies a nanocomplex capable of releasing NO and αPD-L1 in the tumor to a solid tumor model, successfully inhibiting tumor growth by altering the immunosuppressive environment through improved penetration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B7-H1 AntigenCollagenNitric OxideNeoplasmsImmune Checkpoint InhibitorsAnimalsImmunotherapyTumor MicroenvironmentMiceCell Line, TumorHumansFemaleReactive Oxygen SpeciesProdrugsT-Lymphocytes, CytotoxicDrug LiberationExtracellular MatrixMice, Inbred C57BLMice, Inbred BALB CNanoparticles

Stichwörter der Autor:innen

Deep penetrationImmune checkpoint blockadeNitric oxideReactive oxygen speciesTumor extracellular matrix

Substanzen

B7-H1 AntigenCollagenNitric OxideImmune Checkpoint InhibitorsReactive Oxygen SpeciesProdrugs

Autor:innen und Institutionen

  • Department of Chemistry, POSTECH-CATHOLIC Biomedical Engineering Institute (POSTECH), Pohang 37673, South Korea.
  • Department of Chemistry, POSTECH-CATHOLIC Biomedical Engineering Institute (POSTECH), Pohang 37673, South Korea. Electronic address: wjkim@postech.ac.kr.

Förderung

  • Korea Ministry of Science and ICT
  • National Research Foundation of Korea

Zitieren

APA

Lee, J., Cho, H., Kim, J., Lim, J., Kang, Y., & Kim, W. J. (2025). Breaking barriers: Nitric oxide-releasing nanocomplexes for collagen degradation and enhanced αPD-L1 immunotherapy in deep tumor. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2025.02.072

Vancouver

Lee J, Cho H, Kim J, Lim J, Kang Y, Kim WJ. Breaking barriers: Nitric oxide-releasing nanocomplexes for collagen degradation and enhanced αPD-L1 immunotherapy in deep tumor. Journal of Controlled Release. 2025. doi:10.1016/j.jconrel.2025.02.072

BibTeX
@article{Lee2025,
  author = {Lee, Jihye and Cho, Hyoeun and Kim, Jieun and Lim, Junha and Kang, Yeoul and Kim, Won Jong},
  title = {Breaking barriers: Nitric oxide-releasing nanocomplexes for collagen degradation and enhanced αPD-L1 immunotherapy in deep tumor},
  journal = {Journal of Controlled Release},
  year = {2025},
  doi = {10.1016/j.jconrel.2025.02.072}
}
Kostenlos starten →